Prof Dr. HU JIHONG | Innovative Leadership | Best Researcher Award

Prof Dr. HU JIHONG | Innovative Leadership | Best Researcher Award

GANSU UNIVERSITY OF CHINESE MEDICINE, CHINA

Profile 

Google Scholar 

🎓 Early Academic Pursuits

Jihong Hu embarked on her academic journey in the field of Preventive Medicine at Ningxia Medical University in 1995. She pursued her undergraduate degree, which she completed in 2003, followed by a Master’s degree in 2000, laying the foundation of her future expertise in epidemiology and health statistics. Her passion for public health led her to Peking Union Medical College, where she completed her Doctorate in Epidemiology and Health Statistics in 2007. This period marked the beginning of her specialized research into the intersection of preventive medicine, epidemiology, and public health statistics. These formative years equipped her with the critical tools to address large-scale health issues through research and policy-oriented solutions.

👩‍🔬 Professional Endeavors

Jihong Hu’s career as a professor has spanned over two decades, during which she has continually contributed to scientific knowledge, particularly in the realms of epidemiology and preventive medicine. She has led numerous national and regional projects focused on chronic diseases, traditional Chinese medicine (TCM), and cardiovascular health. Her scientific endeavors demonstrate a unique interdisciplinary approach, bridging the gap between modern medicine and traditional Chinese medicine to create holistic solutions to prevalent public health problems. Key projects include the integration of Internet+ technology and Chinese medicine in managing chronic diseases and exploring the effects of intestinal microecological imbalances on pediatric health.

In addition, her leadership in the Gansu Provincial Major Special Projects has advanced the standardization of TCM treatments, particularly in managing conditions such as lumbar intervertebral disc herniation. Her work as part of the Chinese Academy of Medical Sciences (CAMS) has also explored environmental and epigenetic factors in cardiovascular diseases, reinforcing her expertise in the prevention and early intervention of chronic conditions.

🔬 Contributions and Research Focus

Jihong Hu’s research primarily revolves around three core areas: chronic disease prevention, the intersection of traditional Chinese medicine with modern healthcare, and cardiovascular health. A notable aspect of her work is her focus on pediatric health, especially in the application of traditional Chinese medicine to address pediatric respiratory infections. She has extensively studied the gut microbiome’s role in influencing various health conditions, including obesity and hypertension, highlighting the growing relevance of microbiology in chronic disease management.

Her research also encompasses the salt sensitivity of blood pressure, contributing vital knowledge to understanding the effects of diet on cardiovascular health. These efforts have earned her multiple grants from the National Natural Science Foundation of China, affirming her position as a leading figure in chronic disease research in China.

Among her published works are significant findings on the correlation between air pollution and respiratory diseases in children, as well as the effects of salt substitutes on hypertensive patients, showcasing her commitment to addressing health issues on a macro level.

🏅 Accolades and Recognition

Jihong Hu has received national and provincial funding for several major research projects, emphasizing her prominent role in advancing public health. Her work has earned recognition from the academic community, particularly for her role as both a first author and corresponding author in numerous high-impact journals.

Her research on the effects of salt substitutes, published in Clinical and Experimental Hypertension, is widely cited and has influenced hypertension management strategies in China. Additionally, her meta-analyses on the efficacy of acupuncture in stroke rehabilitation, published in the Journal of Gansu University of Chinese Medicine, have contributed to the validation of TCM therapies in modern clinical practices.

🌍 Impact and Influence

Jihong Hu’s work has made significant strides in preventive medicine and public health, especially in the application of integrative approaches involving traditional Chinese medicine and modern healthcare systems. Her findings on the gut microbiome’s connection to chronic diseases like hypertension and obesity have opened new avenues for understanding these complex conditions. The impact of her research transcends the academic realm, influencing clinical practices and public health policies aimed at reducing chronic disease burden in China.

Furthermore, her work on pediatric health, particularly in Lanzhou, has shed light on the critical role of environmental factors in children’s respiratory health. Her contributions have not only improved the understanding of disease etiology but have also prompted better preventative measures at the regional and national levels.

🏅 Legacy and Future Contributions

Looking ahead, Jihong Hu’s work will likely continue to shape the fields of public health, preventive medicine, and integrative healthcare. Her research into the dynamic changes in ischemic stroke diagnosis and treatment, particularly through traditional Chinese medicine, holds promising implications for stroke management in China and beyond. Moreover, her contributions to chronic disease surveillance systems will remain invaluable as global healthcare systems adapt to the growing burden of non-communicable diseases.

Her future work is expected to build upon the successes of her past projects, further advancing the integration of TCM and modern medicine for holistic patient care. With her reputation as a scholar and leader in preventive medicine, Jihong Hu’s legacy will likely include significant breakthroughs in chronic disease prevention and innovative therapeutic approaches rooted in traditional medicine.

In conclusion, Jihong Hu’s extensive academic and research career has established her as a pioneer in combining modern epidemiology with traditional Chinese medical practices. Her work continues to have a profound impact on public health policies, chronic disease prevention, and pediatric healthcare in China.

📝Notable Publications

Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research | 2803

Prof Dr. Chi-Tai Yeh | Innovative Leadership | Excellence in Research

Prof Dr. Chi-Tai Yeh,Taipei Medical University-Shuang Ho Hospital,

 Professional Profile

Education 🎓

  • Post-Doctoral Fellow | Jan 2006 – Jan 2010
    National Institute of Cancer Research, Taiwan (R.O.C)
    National Health Research Institutes
  • Ph.D. in Food Science and Biotechnology | Aug 2001 – Aug 2005
    National Chung Hsing University, Taiwan (R.O.C)

Current Positions 📈

  • Professor | Apr 2021 – Present
    Continuing Education Program of Food Biotechnology Applications, College of Science and Engineering, National Taitung University, Taiwan (R.O.C)
  • Joint Appointment Research Fellow and Executive Secretary | Feb 2014 – Present
    Department of Research, Taipei Medical University – Shuang Ho Hospital, Taiwan (R.O.C)
  • Assistant Professor | Apr 2010 – Present
    Graduate Institute of Clinical Medicine, Taipei Medical University, Taiwan (R.O.C)

Professional Appointments and Experience 💼

  • Authored 91 articles in cancer and nutritional chemistry journals 📄
  • Contributed to 2 book chapters 📚
  • Secured 6 patents in cancer therapy compounds 🔬
  • Research Focus:
    • Cancer cell biology
    • Cancer stem cell studies
    • Nutrigenomics
    • Cancer prevention using dietary phytochemicals 🍎
  • Key Objectives:
    • Disrupt tumor growth and survival pathways
    • Enhance chemosensitivity and/or radiosensitivity
    • Develop methods to counter tumor metastasis
    • Test therapeutic interventions with tumor metastasis suppressor genes in preclinical trials
    • Employ high-throughput proteomic analysis to discover new tumor metastasis markers and evaluate therapeutic approaches

Notable Achievements 🏆

  • 5292 Citations 📈
  • h-Index: 42 🎖️
  • Developed new methods to counter tumor metastasis and enhance treatment efficacy in cancer therapy

Publication Top Noted:

  • Paper Title: PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma
  • Paper Title: Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma
  • Paper Title:  Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death
  • Paper Title: Correction: Chen et al. Hydroxychloroquine (HCQ) Modulates Autophagy and Oxidative DNA Damage Stress in Hepatocellular Carcinoma to Overcome Sorafenib Resistance via TLR9/SOD1/hsa-miR-30a-5p/Beclin-1 Axis. Cancers 2021, 13, 3227
  • Paper Title: Cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to Bone Prometastatic Factor of Breast Cancer Progression

Eros Montin-Innovative Leadership-Best Researcher Award 

Eros Montin-Innovative Leadership-Best Researcher Award 

New York University Grossman School of Medicine-United States

Author Profile 

Early Academic Pursuits

Eros Montin embarked on his academic journey with a Bachelor's degree in Biomedical Engineering from Politecnico di Milano. His thesis, "Dal Pensiero al Movimento" (From Thought to Movement), showcased his early interest in EEG data analysis and event-related potential (ERD/ERS) related to patient movement.

He continued his academic pursuits with a Master's degree in Biomedical Engineering, exploring cortical attentional systems using functional magnetic resonance imaging (fMRI) during a continuous performance test. Eros delved into the identification of brain regions involved in blood oxygen level-dependent (BOLD) response during cognitive tasks.

For his Doctoral Degree in Bioengineering, he developed a novel image registration strategy for oncological pediatric brain images fusion. His commitment to advancing medical imaging techniques was evident in his research focused on improving prognostic predictions in Head and Neck Cancer.

Professional Endeavors

Eros Montin's professional journey started as the Manager of Intermodal Logistics at HUPAC S.P.A., showcasing his versatility beyond the biomedical field. He later joined the Radiology Department of the National Cancer Institute in Milan as a Postgraduate Research Fellow, focusing on parameters calculation from diffusion-weighted imaging and perfusion-weighted imaging.

During his Postdoctoral Research Fellowships at Politecnico di Milano and NYU School of Medicine, Eros spearheaded software development for Cloud MR, a project dedicated to the design and evaluation of radiofrequency coils for magnetic resonance imaging applications. He contributed to significant advancements in radiomics and AI, emphasizing their potential in clinical and translational medicine.

Contributions and Research Focus

Eros Montin's contributions extend across various domains, including radiomics, machine learning, and big data applications in biomedical imaging. His work on web-based applications like MR Optimum, CAMRIE, and Coil Designer demonstrates his commitment to advancing MRI technology. Additionally, his involvement in the BD2Decide project aimed at precise prognostic predictions in Head and Neck Cancer showcases his dedication to impactful research.

Accolades and Recognition

Eros Montin's expertise in biomedical imaging and machine learning earned him the position of Leading Editor for a Research Topic titled "Radiomics and AI for clinical and translational medicine" in Frontiers in Radiology. His significant achievements were acknowledged with the 2022 ISMRM Magna Cum Laude Merit Award for his oral presentation on TESS, a web-accessible tool for temperature estimation from SAR simulation.

Impact and Influence

Eros Montin's impact is evident in his editorial role, shaping the discourse in radiomics and AI. His contributions to the development of Cloud MR and innovative web applications have influenced the field of biomedical imaging, providing valuable tools for researchers and clinicians. His commitment to advancing technology-driven healthcare reform underscores his influence on healthcare practices.

Legacy and Future Contributions

Eros Montin's legacy lies in his multifaceted contributions to biomedical research, software development, and healthcare innovation. His future contributions are anticipated to further bridge the gap between technology and healthcare, with a focus on enhancing diagnostic precision and patient outcomes. As a seasoned professional with a proven track record, Eros remains dedicated to transformative change in the medical field.

Notable Publications